Ticker Symbol: LXRX
Lexicon Pharmaceuticals Inc
$5.09 - 20-11-2024 4 p.m. ET
Exchange: NASDAQ
Currency:
USD
Asset
Type: Common Stock
CIK:0001062822
Company Profile
Lexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients' lives. Through its Genome5000™ program, Lexicon scientists studied the role and function of nearly 5,000 genes and identified more than 100 protein targets with significant therapeutic potential in a range of diseases. Through the precise targeting of these proteins, Lexicon is pioneering the discovery and development of innovative medicines to safely and effectively treat disease. Lexicon advanced one of these medicines to market and has a pipeline of promising drug candidates in discovery and clinical and preclinical development in neuropathic pain, heart failure, diabetes and metabolism and other indications.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: N/A
Website: www.lexpharma.com
CEO: N/A
Tags:
- Health Technology
- Biotechnology
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $1.04
Change:
$0.02
(
1.96%)
Days Range: $0.96 - $1.04
Beta: 1.67
52wk. High: $3.79
52wk. Low: $0.95
Ytd. Change -44.64%
50 Day Moving Average: $1.25
200 Day Moving Average: $2.09
Shares Outstanding: 244924695
Valuation
Market Cap: 25.5B
PE Ratio: -1.51
EPS (TTM): -0.6898
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A